| Toward a better understanding of the complexity of cancer drug resistance MM Gottesman, O Lavi, MD Hall, JP Gillet Annual review of pharmacology and toxicology 56, 85-102, 2016 | 317 | 2016 |
| The dynamics of drug resistance: a mathematical perspective O Lavi, MM Gottesman, D Levy Drug Resistance Updates 15 (1-2), 90-97, 2012 | 112 | 2012 |
| The role of cell density and intratumoral heterogeneity in multidrug resistance O Lavi, JM Greene, D Levy, MM Gottesman Cancer research 73 (24), 7168-7175, 2013 | 71 | 2013 |
| Redundancy: a critical obstacle to improving cancer therapy O Lavi Cancer research 75 (5), 808-812, 2015 | 59 | 2015 |
| The impact of cell density and mutations in a model of multidrug resistance in solid tumors J Greene, O Lavi, MM Gottesman, D Levy Bulletin of mathematical biology 76, 627-653, 2014 | 45 | 2014 |
| Modeling intrinsic heterogeneity and growth of cancer cells JM Greene, D Levy, KL Fung, PS Souza, MM Gottesman, O Lavi Journal of theoretical biology 367, 262-277, 2015 | 42 | 2015 |
| Computational modeling demonstrates that glioblastoma cells can survive spatial environmental challenges through exploratory adaptation O Celiku, MR Gilbert, O Lavi Nature Communications 10 (1), 5704, 2019 | 28 | 2019 |
| Mathematical modeling reveals that changes to local cell density dynamically modulate baseline variations in cell growth and drug response JM Greene, D Levy, SP Herrada, MM Gottesman, O Lavi Cancer Research 76 (10), 2882-2890, 2016 | 27 | 2016 |
| Listeriosis: a model for the fine balance between immunity and morbidity O Lavi, Y Louzoun, E Klement Epidemiology 19 (4), 581-587, 2008 | 19 | 2008 |
| Simplifying the complexity of resistance heterogeneity in metastasis O Lavi, JM Greene, D Levy, MM Gottesman Trends in molecular medicine 20 (3), 129-136, 2014 | 16 | 2014 |
| Phenotype stability under dynamic brain-tumor environment stimuli maps glioblastoma progression in patients VN Rajapakse, S Herrada, O Lavi Science advances 6 (22), eaaz4125, 2020 | 11 | 2020 |
| Network features suggest new hepatocellular carcinoma treatment strategies O Lavi, J Skinner, MM Gottesman BMC systems biology 8, 1-15, 2014 | 11 | 2014 |
| Tracking the adaptation and compensation processes of patients brain arterial network to an evolving glioblastoma J Zhu, S Teolis, N Biassou, A Tabb, PE Jabin, O Lavi IEEE Transactions on Pattern Analysis and Machine Intelligence, 1-1, 2020 | 10 | 2020 |
| Regulation of modular Cyclin and CDK feedback loops by an E2F transcriptionoscillator in the mammalian cell cycle O Lavi, D Ginsberg, Y Louzoun Mathematical Biosciences & Engineering 8 (2), 445-461, 2011 | 9 | 2011 |
| Effect of vaccination in environmentally induced diseases O Lavi, E Klement, Y Louzoun Bulletin of mathematical biology 73, 1101-1117, 2011 | 2 | 2011 |
| What cycles the cell?–Robust autonomous cell cycle models O Lavi, Y Louzoun Mathematical Medicine and Biology: A Journal of the IMA 26 (4), 337-359, 2009 | 2 | 2009 |
| COMP-08. SURVIVING BY EXPLORING: COULD GLIOBLASTOMA CELLS FOLLOW THE THEORY OF EXPLORATORY ADAPTATION? O Celiku, M Gilbert, O Lavi Neuro-Oncology 20 (Suppl 6), vi65, 2018 | | 2018 |
| Implications of cell-to-cell dynamic baseline variation on drug sensitivity measurements JM Greene, D Levy, SP Herrada, MM Gottesman, O Lavi EUROPEAN JOURNAL OF CANCER 54, S68-S69, 2016 | | 2016 |
Doron LevyUniversity of MarylandVerified email at umd.edu
